“…Simultaneously, excessive levels of Al 3+ in the body can lead to serious diseases such as dementia, PD, and Alzheimer’s disease. Studies showed that the level of HVA decreases while the concentration of Al 3+ increases in PD patients. − Thus, simultaneous detection of HVA and Al 3+ is of great significance for the early diagnosis and monitoring of PD. Currently, the detection methods of HVA or Al 3+ included enzymatic immunological assays (EIA), liquid chromatography (LC), gas chromatography–mass spectrometry (GC–MS), and high-performance liquid chromatography (HPLC). − However, these methods have some shortcomings such as the lack of specificity, poor sensitivity, large reagent consumption, and individual determination …”